The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,894
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. (2001) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.15 · Cited by 3,288
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Synthesis and Function of 3-Phosphorylated Inositol Lipids
Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., & Waterfield, M. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.535 · Cited by 1,535 · cited 1×
“…& 2003 Nature Publishing Group All rights reserved 0950-9232/03 $25.00 www.nature.com/onc By activating the phosphoinositide-dependent kinase-1 and recruiting the serine/threonine kinase Akt to the plasma membrane, PI3K leads to the phosphorylation of Thr308 of Akt (Vanhaesebroeck et al., 2001).”
BackgroundInfluentialExpression of Multidrug Resistance Gene in Human Cancers
Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S.-L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., et al. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.116 · Cited by 1,290
Aberrant rel/nfkb genes and activity in human cancer
Rayet, B., & Gélinas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203221 · Cited by 1,110
Brunn, G. J., Williams, J., Sabers, C., Wiederrecht, G., Lawrence, J. C., & Abraham, R. T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00911.x · Cited by 723
Madrid, L. V., Wang, C.-Y., Guttridge, D. C., Schottelius, A. J. G., Baldwin, A. S., & Mayo, M. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1626-1638.2000 · Cited by 540
Preoperative Staging and Assessment of Resectability of Pancreatic Cancer
Warshaw, A. L. (1990) · Archives of Surgery · doi:10.1001/archsurg.1990.01410140108018 · Cited by 471
Genetic profile of 22 pancreatic carcinoma cell lines: Analysis of K-ras, p53, p16 and DPC4/Smad4
Moore, P. S., Sipos, B., Orlandini, S., Sorio, C., Real, F. X., Lemoine, N. R., Gress, T., Bassi, C., Klöppel, G., Kalthoff, H., et al. (2001) · Virchows Archiv · doi:10.1007/s004280100474 · Cited by 329
Weber, C. K., Liptay, S., Wirth, T., Adler, G., & Schmid, R. M. (2000) · Gastroenterology · doi:10.1053/gast.2000.19458 · Cited by 299
The pro‐ or anti‐apoptotic function of NF‐κB is determined by the nature of the apoptotic stimulus
Kaltschmidt, B., Kaltschmidt, C., Hofmann, T. G., Hehner, S. P., Dröge, W., & Schmitz, M. L. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01421.x · Cited by 252
Eosewicz, S., & Wiedenmann, B. (1997) · The Lancet · doi:10.1016/s0140-6736(96)05523-7 · Cited by 229
Arlt, A., Vorndamm, J., Breitenbroich, M., Fölsch, U. R., Kalthoff, H., Schmidt, W. E., & Schäfer, H. (2001) · Oncogene · doi:10.1038/sj.onc.1204168 · Cited by 227
Self-citationExpression profiling of microdissected pancreatic adenocarcinomas
Crnogorac-Jurcevic, T., Efthimiou, E., Nielsen, T., Loader, J., Terris, B., Stamp, G., Baron, A., Scarpa, A., & Lemoine, N. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205570 · Cited by 225
Phosphatidylinositol 3-Kinase as a Mediator of TNF-Induced NF-κB Activation
Reddy, S. A. G., Huang, J. H., & Liao, W. S.-L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1355 · Cited by 178
Gemcitabine: A cytidine analogue active against solid tumors
Hui, Y. F., & Reitz, J. (1997) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/54.2.162 · Cited by 177
Trauzold, A., Wermann, H., Arlt, A., Schütze, S., Schäfer, H., Oestern, S., Röder, C., Ungefroren, H., Lampe, E., Heinrich, M., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204559 · Cited by 168
Self-citationNF-κB Activation Mediates Doxorubicin-induced Cell Death in N-type Neuroblastoma Cells
Bian, X., McAllister‐Lucas, L. M., Shao, F., Schumacher, K. R., Feng, Z., Porter, A. G., Castle, V. P., & Opipari, A. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108674200 · Cited by 166
Dong, Q. G., Sclabas, G. M., Fujioka, S., Schmidt, C., Peng, B., Wu, T., Tsao, M.-S., Evans, D. B., Abbruzzese, J. L., McDonnell, T. J., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205848 · Cited by 166
Constitutive activation of nuclear factor-κB prevents TRAIL-induced apoptosis in renal cancer cells
Oya, M., Ohtsubo, M., Takayanagi, A., Tachibana, M., Shimizu, N., & Murai, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204525 · Cited by 164
Wang, W., Abbruzzese, J. L., Evans, D. B., & Chiao, P. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202833 · Cited by 161
Dumontet, C., Fabianowska‐Majewska, K., Mantincic, D., Callet‐Bauchu, E., Tigaud, I., Gandhi, V. V., Lepoivre, M., Peters, G. J., Rolland, M. O., Wyczechowska, D. D., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01509.x · Cited by 151
Expression of a non‐functional p53 affects the sensitivity of cancer cells to gemcitabine
Galmarini, C. M., Clarke, M. L., Falette, N., Puisieux, A., Mackey, J. R., & Dumontet, C. (2001) · International Journal of Cancer · doi:10.1002/ijc.1628 · Cited by 100
Inhibition of NF-κB activation in vitro and in vivo: Role of 26S proteasome
Grisham, M. B., Palombella, V. J., Elliott, P. J., Conner, E. M., Brand, S. J., Wong, H. L., Pien, C. S., Mazzola, L. M., Destree, A. T., Parent, L. A., et al. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)00140-8 · Cited by 99
NFkB-dependent chemoresistance in solid tumors
Arlt, A., & Schäfer, H. (2002) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp40336 · Cited by 78
Self-citationSchäfer, H., Diebel, J., Arlt, A., Trauzold, A., & Schmidt, W. E. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01109-0 · Cited by 75
Self-citationTreatment of pancreatic cancer
Rosenberg, L. (1997) · International Journal of Pancreatology · doi:10.1007/bf02787465 · Cited by 36
Cited by
Molecular mechanisms of drug resistance
Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,672
Genetics and biology of pancreatic ductal adenocarcinoma
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,577
Apoptosis and Molecular Targeting Therapy in Cancer
Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y., & Sakuragi, N. (2014) · BioMed Research International · doi:10.1155/2014/150845 · Cited by 1,121
RetractedCancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells
Richards, K. E., Zeleniak, A. E., Fishel, M. L., Wu, J., Littlepage, L. E., & Hill, R. (2017) · Oncogene · doi:10.1038/onc.2016.353 · Cited by 735
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
Nakanishi, C., & Toi, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1588 · Cited by 724
Metadata
- Authors
- Arlt, A., Gehrz, A., Müerköster, S., Vorndamm, J., Kruse, M.-L., Fölsch, U. R., & Schäfer, H.
- Venue
- Oncogene
- Published
- 2003-05-22
- Volume
- 22
- Issue
- 21
- Pages
- 3243-3251
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2000932071
- Cited by
- 474
- References
- 32
- FWCI
- 8.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.